• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

3

CATEGORIES

  • 17
  • 15
  • 12
  • 6
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

5
5
6
56

PUBLISHED

0
6
29
56

PRODUCT TYPE

52
4

Search "Athersys, Inc.-Therapeutic Competitors" returned 56 results.

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review

Athersys, Inc. (ATHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

May 2015
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H1 2014’, provides...

May 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H2 2014’, provides an overview of the...

October 2014
FROM

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015 Summary This, ‘Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) - Pipeline Review, H1 2015’, provides an overview of the...

January 2015
FROM

Ischemic Stroke - Pipeline Review, H2 2014

Ischemic Stroke - Pipeline Review, H2 2014 Summary This, ‘Ischemic Stroke - Pipeline Review, H2 2014’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Regenerative Medicine - Global Trends, Estimates and Forecasts, 2013-2019

Global Market Watch: Global Regenerative Medicine market is estimated to reach US$24.7 billion by 2017. Regenerative Medicine in Orthopedics market is projected to reach US$10.3 billion by 2017,...

April 2015
FROM

Myelodysplastic Syndrome - Pipeline Review, H1 2014

Myelodysplastic Syndrome - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2014’, provides an overview of the Myelodysplastic Syndrome’s therapeutic...

February 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2014’, provides an overview of the Hematopoietic Stem...

October 2014
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015 Summary This, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2015’, provides an overview of the Hematopoietic Stem...

May 2015
FROM

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014

Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hematopoietic Stem Cell Transplantation - Pipeline Review, H1 2014’, provides an overview of the...

April 2014
FROM

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review

Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

June 2015
FROM

Ischemic Stroke - Pipeline Review, H1 2015

Ischemic Stroke - Pipeline Review, H1 2015 Summary: This, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline. This report provides...

March 2015
FROM

Ischemia - Pipeline Review, H2 2014

Ischemia - Pipeline Review, H2 2014 Summary This, ‘Ischemia - Pipeline Review, H2 2014’, provides an overview of the Ischemia’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015 Summary This, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2015’, provides an overview of the Graft Versus Host Disease (GVHD)’s...

March 2015
FROM

Spinal Cord Injury - Pipeline Review, H1 2014

Spinal Cord Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Spinal Cord Injury - Pipeline Review, H1 2014’, provides an overview of the Spinal Cord Injury’s therapeutic pipeline. This...

February 2014
FROM

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015

Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015 Summary This, ‘Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015’, provides an overview of the Peripheral...

March 2015
FROM

Traumatic Brain Injury - Pipeline Review, H2 2014

Traumatic Brain Injury - Pipeline Review, H2 2014 Summary This, ‘Traumatic Brain Injury - Pipeline Review, H2 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic pipeline. This...

October 2014
FROM

Traumatic Brain Injury - Pipeline Review, H1 2014

Traumatic Brain Injury - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Traumatic Brain Injury - Pipeline Review, H1 2014’, provides an overview of the Traumatic Brain Injury’s therapeutic...

April 2014
FROM

Obesity - Pipeline Review, H1 2015

Obesity - Pipeline Review, H1 2015 Summary This, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

February 2015
FROM

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014

Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2014’, provides an overview of the Graft Versus...

March 2014
FROM
Loading Indicator

Our Clients

Carrefour S.A. Dow Chemical Co Ltd. Motorola Solutions, Inc. Pfizer, Inc. Activision Publishing, Inc. 3M Company Estée Lauder Companies Inc.